C07J 1/0025
Esters
Official title: {Esters}
C07J1/0025 (Esters) appears on 71 US grants and 40 published applications in this corpus.
Search patents in C07J- Granted patents
- 71
- Published applications
- 40
- Assignees
- 33
- Inventors
- 153
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 3 |
| 2009 | 0 | 1 |
| 2010 | 3 | 1 |
| 2011 | 4 | 3 |
| 2012 | 1 | 2 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 2 |
| 2019 | 0 | 3 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 2 | 2 |
| 2023 | 2 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 5 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- (17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use8 Jul 2025US 12,351,600 B2
- Lymph directing prodrugs29 Aug 2023US 11,738,087 B2Monash University
- (17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods of their preparation and use25 Jul 2023US 11,707,467 B2
- (17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use28 Jun 2022US 11,370,811 B1
- Lymph directing prodrugs26 Apr 2022US 11,311,512 B2Monash University
- Lymph directing prodrugs24 Sep 2026US 2026/0284004 A1Monash University
- Lymph directing prodrugs4 Jun 2026US 2026/0151489 A1Monash University
- Lymph directing prodrugs16 Apr 2026US 2026/0102373 A1Monash University
- Prodrugs for delivery of testosterone to the central nervous system15 Jan 2026US 2026/0014170 A1
- Lymph directing prodrugs1 Jan 2026US 2026/0000769 A1Monash University
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Oral pharmaceutical preparation85US 4,147,783 AAkzona Incorporated · 1979
- 17-Hydroxy-steroids72US 4,898,694 A1990
- Method of treatment of androgen-related diseases48US 5,372,996 AEndorecherche, Inc. · 1994
- Oral pharmaceutical preparation having androgenic activity45US 4,098,802 AAkzona Incorporated · 1978